Market Failure and Externalities: Question 3
Syllabus 7.4
Bellview Health Clinic offers seasonal flu vaccinations to the public. Because a vaccinated person is less likely to catch and spread flu to others, each vaccination also protects people who are not vaccinated themselves. A benefit that vaccinated individuals do not personally receive and that is not reflected in the price they pay for the vaccination. There is no externality on the cost side, so marginal private cost equals marginal social cost throughout.
The table below shows, at different monthly output levels, the marginal private benefit (MPB) to the person being vaccinated, the constant marginal external benefit (MEB) to the rest of the population, the resulting marginal social benefit (MSB), and the marginal private cost (MPC), which equals marginal social cost (MSC).
| Output (thousand vaccinations per month) | MPB ($ per dose) | MEB ($ per dose) | MSB = MPB + MEB ($ per dose) | MPC = MSC ($ per dose) |
|---|---|---|---|---|
| 0 | 70 | 20 | 90 | 10 |
| 1 | 60 | 20 | 80 | 20 |
| 2 | 50 | 20 | 70 | 30 |
| 3 | 40 | 20 | 60 | 40 |
| 4 | 30 | 20 | 50 | 50 |
| 5 | 20 | 20 | 40 | 60 |
| 6 | 10 | 20 | 30 | 70 |
(a) Explain, using the concepts of marginal private benefit and marginal social benefit, why flu vaccinations generate a positive externality of consumption. [2]
(b) Using the table, identify the free-market output, where MPB = MPC, and the socially optimal output, where MSB = MSC, and state whether the free market under-provides or over-provides vaccinations relative to the socially optimal level. [3]
(c) Calculate the marginal external benefit per dose at the free-market output, and use it, together with your answers to part (b), to calculate the deadweight welfare loss that results from the clinic providing the free-market quantity of vaccinations rather than the socially optimal quantity. [4]
Show worked solution Hide worked solution
Worked solution
Part (a): Why this is a positive externality of consumption
Bellview Health Clinic’s patients pay for a flu vaccination based on the private protection it gives them, being less likely to catch flu themselves. But a vaccinated person is also less likely to pass flu on to other people, including those who are not vaccinated, which reduces flu transmission across the wider population.
This means:
where is the marginal external benefit (the reduced-transmission benefit enjoyed by everyone else. Because the clinic’s patients only take account of their own when deciding whether to get vaccinated, fewer vaccinations are demanded than is socially desirable) this uncompensated third-party benefit is exactly what defines a positive externality of consumption.
Part (b): Free-market output and socially optimal output
Free-market output: individuals choose to be vaccinated up to the point where their own marginal private benefit equals the marginal private cost of a dose, . Reading the table, at an output of 3 thousand vaccinations, and , both equal $40 per dose. So the free-market output is 3 thousand vaccinations per month.
Socially optimal output: allocative efficiency requires marginal social benefit to equal marginal social cost, . At an output of 4 thousand vaccinations, and , both equal $50 per dose. So the socially optimal output is 4 thousand vaccinations per month.
Because the free-market output (3 thousand) is below the socially optimal output (4 thousand), the positive externality causes the market to under-provide vaccinations relative to what is socially efficient.
Part (c): External benefit and deadweight welfare loss
At the free-market output of 3 thousand vaccinations per month:
So the marginal external benefit is $20 per dose at this output.
Between the free-market output (3 thousand) and the socially optimal output (4 thousand), the gap between and narrows from $20 per dose (at 3 thousand, where ) down to $0 (at 4 thousand, where ). Since both and change at a constant rate with output, this gap shrinks in a straight line, so the deadweight welfare loss is the area of a triangle:
Because output is measured in thousand vaccinations, this deadweight welfare loss of represents $10 thousand ($10,000) per month. The value of the social benefit foregone because too few people are vaccinated between the free-market and socially optimal quantities.
Final answers
- (a) MSB exceeds MPB because of the uncompensated marginal external benefit (reduced flu transmission) enjoyed by others
- (b) Free-market output = 3 thousand vaccinations/month; socially optimal output = 4 thousand vaccinations/month; the free market under-provides vaccinations
- (c) MEB at the free-market output = $20 per dose; deadweight welfare loss = $10 thousand ($10,000) per month